Hirayama et al., 2012 - Google Patents
Detection of dengue virus genome in urine by real-time reverse transcriptase PCR: a laboratory diagnostic method useful after disappearance of the genome in serumHirayama et al., 2012
View PDF- Document ID
- 7189598027373959325
- Author
- Hirayama T
- Mizuno Y
- Takeshita N
- Kotaki A
- Tajima S
- Omatsu T
- Sano K
- Kurane I
- Takasaki T
- Publication year
- Publication venue
- Journal of clinical microbiology
External Links
Snippet
The reemergence of dengue virus (DENV) infection has created a requirement for improved laboratory diagnostic procedures. In this study, DENV genome detection in urine was evaluated as a diagnostic method. The DENV genome was detected by real-time reverse …
- 210000002700 Urine 0 title abstract description 90
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hirayama et al. | Detection of dengue virus genome in urine by real-time reverse transcriptase PCR: a laboratory diagnostic method useful after disappearance of the genome in serum | |
| Shu et al. | Dengue virus serotyping based on envelope and membrane and nonstructural protein NS1 serotype-specific capture immunoglobulin M enzyme-linked immunosorbent assays | |
| Abbaszadegan et al. | Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran | |
| Sam et al. | Updates on chikungunya epidemiology, clinical disease, and diagnostics | |
| Klutts et al. | Evidence-based approach for interpretation of Epstein-Barr virus serological patterns | |
| Lustig et al. | Superiority of West Nile virus RNA detection in whole blood for diagnosis of acute infection | |
| Nasrallah et al. | Seroprevalence of hepatitis E virus among blood donors in Qatar (2013‐2016) | |
| Hogrefe et al. | Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus-and other flavivirus-specific antibodies | |
| Hogrefe et al. | Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition | |
| Shu et al. | Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports | |
| Myint et al. | Evaluation of diagnostic assays for hepatitis E virus in outbreak settings | |
| Ding et al. | Full serotype-and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection | |
| Ward et al. | Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections | |
| Levett et al. | Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus | |
| Schilling et al. | Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin | |
| Shan et al. | Evaluation of a novel reporter virus neutralization test for serological diagnosis of Zika and dengue virus infection | |
| Nawa et al. | Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay | |
| Domingo et al. | Detection of yellow fever 17D genome in urine | |
| Nandakumar et al. | Evaluation of a surrogate enzyme-linked immunosorbent assay–based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cPass neutralization antibody detection assay and correlation with immunoglobulin G commercial serology assays | |
| Meldal et al. | Hepatitis E virus infection in Ghanaian blood donors–the importance of immunoassay selection and confirmation | |
| Kramme et al. | Orientia tsutsugamushi bacteremia and cytokine levels in Vietnamese scrub typhus patients | |
| Prince et al. | Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of chikungunya virus in the Americas | |
| Van den Bossche et al. | Recovery of dengue virus from urine samples by real-time RT-PCR | |
| Nemg Simo et al. | Investigation of an outbreak of dengue virus serotype 1 in a rural area of Kribi, South Cameroon: a cross-sectional study | |
| Gasasira et al. | False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria |